Polylactide-Based Materials: Synthesis and Biomedical Applications
This reprint focuses on PLA-based materials and the modification of their properties for biomedical applications. Special emphasis is placed on the supramolecular strategies that lead to unique structures in the micro- or nanoscale. The development and testing of novel biomaterials as drug delivery...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 05142namaa2201513uu 4500 | ||
|---|---|---|---|
| 001 | doab98781 | ||
| 003 | oapen | ||
| 005 | 20230405 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 230405s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a 9783036561264 | ||
| 020 | |a 9783036566412 | ||
| 020 | |a books978-3-0365-6641-2 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-6641-2 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 072 | 7 | |a TDC |2 bicssc | |
| 720 | 1 | |a Brzeziński, Marek |4 edt | |
| 720 | 1 | |a Baśko, Małgorzata |4 edt | |
| 720 | 1 | |a Baśko, Małgorzata |4 oth | |
| 720 | 1 | |a Brzeziński, Marek |4 oth | |
| 245 | 0 | 0 | |a Polylactide-Based Materials: Synthesis and Biomedical Applications |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 online resource (376 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a This reprint focuses on PLA-based materials and the modification of their properties for biomedical applications. Special emphasis is placed on the supramolecular strategies that lead to unique structures in the micro- or nanoscale. The development and testing of novel biomaterials as drug delivery carriers, implants, or tissue engineering scaffolds are of particular interest. Special attention is given to understanding the structure-properties relationship, since this allows for the development of the most effective biocompatible materials. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Industrial chemistry and chemical engineering |2 bicssc | |
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 653 | |a ammonium polyphosphate | ||
| 653 | |a anoikis | ||
| 653 | |a anticancer agent | ||
| 653 | |a biocompatibility | ||
| 653 | |a biodegradable materials | ||
| 653 | |a biodegradable polymers | ||
| 653 | |a biodegradation | ||
| 653 | |a biomaterial | ||
| 653 | |a biomaterials | ||
| 653 | |a biomedical and environmental applications | ||
| 653 | |a biomedical applications | ||
| 653 | |a block copolymers | ||
| 653 | |a bone regeneration | ||
| 653 | |a chemical modification | ||
| 653 | |a cochlear implant | ||
| 653 | |a compatibilization | ||
| 653 | |a composite scaffold | ||
| 653 | |a composites | ||
| 653 | |a controlled release | ||
| 653 | |a copolymers | ||
| 653 | |a crosslinking | ||
| 653 | |a crosslinking in situ | ||
| 653 | |a crystallinity | ||
| 653 | |a crystallization | ||
| 653 | |a cyclodextrin | ||
| 653 | |a diclofenac | ||
| 653 | |a drug delivery | ||
| 653 | |a drug delivery system | ||
| 653 | |a drug delivery systems | ||
| 653 | |a dual drug delivery | ||
| 653 | |a electron-beam | ||
| 653 | |a electrospinning | ||
| 653 | |a fibrillar nuclei | ||
| 653 | |a flame retardancy | ||
| 653 | |a functionalized polymers | ||
| 653 | |a gamma rays | ||
| 653 | |a glass fibres | ||
| 653 | |a graft copolymers | ||
| 653 | |a guide tissue engineering | ||
| 653 | |a hybrid network | ||
| 653 | |a impedance measurements | ||
| 653 | |a irradiation | ||
| 653 | |a Leishmania major | ||
| 653 | |a lesion swelling | ||
| 653 | |a linear ladder-like poly(silsesquioxane) | ||
| 653 | |a lung cancer | ||
| 653 | |a mechanical properties | ||
| 653 | |a metastasis | ||
| 653 | |a MWCNT | ||
| 653 | |a n/a | ||
| 653 | |a nanoparticles | ||
| 653 | |a paclitaxel resistance | ||
| 653 | |a parasite' challenge | ||
| 653 | |a PCL | ||
| 653 | |a PHBV | ||
| 653 | |a photo-crosslinking | ||
| 653 | |a PLA nanoparticles | ||
| 653 | |a PLA-based materials | ||
| 653 | |a plasticization | ||
| 653 | |a PLLA | ||
| 653 | |a PLLA coating | ||
| 653 | |a poly(ethylene glycol) | ||
| 653 | |a poly(L-lactide) | ||
| 653 | |a poly(lactic acid) | ||
| 653 | |a poly(lactide) | ||
| 653 | |a polyester biomaterials | ||
| 653 | |a polyesters | ||
| 653 | |a polylactic acid | ||
| 653 | |a polylactic acid (PLA) nanofibers | ||
| 653 | |a polylactide | ||
| 653 | |a polylactide nonwovens | ||
| 653 | |a polylactide-based materials | ||
| 653 | |a polymer | ||
| 653 | |a polymer blends | ||
| 653 | |a reactive blending | ||
| 653 | |a recombinant histone H2B | ||
| 653 | |a reinforced fibers | ||
| 653 | |a scanning electron microscopy | ||
| 653 | |a self-assembly | ||
| 653 | |a sesbania gum | ||
| 653 | |a shear-induced crystallization | ||
| 653 | |a silylated PLA | ||
| 653 | |a soft tissues regeneration | ||
| 653 | |a spiral ganglion neuron | ||
| 653 | |a star poly(L-lactide) | ||
| 653 | |a starch | ||
| 653 | |a stereocomplex | ||
| 653 | |a supramolecular interactions | ||
| 653 | |a vaccine adjuvant | ||
| 653 | |a zirconium ceramic | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/98781 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/6817 |7 0 |z Open Access: DOAB, download the publication |